Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)
Clinical trial NCT03893448 · COMPLETED
Trial details
- NCT number
- NCT03893448
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2021-05-24
- Enrollment
- 1720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.